HMGCR and cancer: Regarding cancer-related mortality, a study observed that statin use in patients with cancer was associated with reduced cancer-related mortality, probably because statins inhibit cholesterol synthesis within cells through the inhibition of HMG-CoA reductase, the rate-limiting enzyme in the mevalonate and cholesterol-synthesis pathway.